| 53.52 Delayed Data As of 4:00pm ET |  +0.04 / +0.07%Today’s Change | 46.94 Today|||52-Week Range 70.05 | -12.66% Year-to-Date |
| Previous close | 53.48 |
| Today’s open | 53.01 |
| Day’s range | 52.90 - 53.81 |
| Volume | 12,617,947 |
| Average volume (3 months) | 7,096,102 |
| Market cap | $87.3B |
| Earnings growth (last year) | -77.15% |
| Earnings growth (this year) | +27.81% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +6.94% |
| P/E ratio | 59.9 |
| Price/Sales | 4.87 |
| Price/Book | 7.40 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | -1.83 | -4.02% |
| GSKGlaxoSmithKline | -0.20 | -0.49% |
| AZNAstraZeneca | -0.46 | -1.13% |
| SNYSanofi | -0.27 | -0.60% |
| Next reporting date | January 24, 2019 |
| EPS forecast (this quarter) | $0.82 |
| Annual revenue (last year) | $20.8B |
| Annual profit (last year) | $1.0B |
| Net profit margin | 4.85% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Giovanni Caforio |
CFO, EVP & Head-Global Business Operations Charles A. Bancroft |
Corporate headquarters New York, New York |
